To determine the DOC (Drug of Choice) for chemotherapy-induced vomiting, we need to consider the primary mechanism and receptors involved in this condition. Chemotherapy often triggers nausea and vomiting by releasing serotonin (5-HT) in the gut, which then binds to 5-HT3 receptors, leading to the emetic reflex. Therefore, drugs that block these 5-HT3 receptors are effective in preventing and treating this kind of nausea and vomiting.
Among the given options:
- Graneseteron: A selective 5-HT3 receptor antagonist used specifically to prevent chemotherapy-induced nausea and vomiting.
- Prazosin: An alpha-1 adrenergic receptor blocker, primarily used for hypertension, not effective for chemotherapy-induced vomiting.
- Clonidine: An alpha-2 adrenergic agonist, used for hypertension and certain withdrawal symptoms, not indicated for chemotherapy-induced vomiting.
- Dimenhydrinate: An antihistamine used to treat motion sickness, not specifically effective against chemotherapy-induced vomiting.
Based on the pharmacological profile and effectiveness:
Correct Answer: Graneseteron